- Home
- INO vs KLTOW Comparison
INO vs KLTOW Comparison
Compare INO & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- KLTOW
- Stock Information
- Founded
- INO 1979
- KLTOW N/A
- Country
- INO United States
- KLTOW United States
- Employees
- INO N/A
- KLTOW 3
- Industry
- INO Medical/Dental Instruments
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INO Health Care
- KLTOW Health Care
- Exchange
- INO Nasdaq
- KLTOW Nasdaq
- Market Cap
- INO N/A
- KLTOW N/A
- IPO Year
- INO 1998
- KLTOW 2022
- Fundamental
- Price
- INO $1.35
- KLTOW $0.24
- Analyst Decision
- INO Buy
- KLTOW
- Analyst Count
- INO 4
- KLTOW 0
- Target Price
- INO $9.75
- KLTOW N/A
- AVG Volume (30 Days)
- INO 2.0M
- KLTOW N/A
- Earning Date
- INO 08-07-2025
- KLTOW N/A
- Dividend Yield
- INO N/A
- KLTOW N/A
- EPS Growth
- INO N/A
- KLTOW N/A
- EPS
- INO N/A
- KLTOW N/A
- Revenue
- INO $283,099.00
- KLTOW N/A
- Revenue This Year
- INO $1,691.91
- KLTOW N/A
- Revenue Next Year
- INO $423.63
- KLTOW N/A
- P/E Ratio
- INO N/A
- KLTOW N/A
- Revenue Growth
- INO N/A
- KLTOW N/A
- 52 Week Low
- INO $1.30
- KLTOW N/A
- 52 Week High
- INO $12.33
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- INO 28.86
- KLTOW N/A
- Support Level
- INO $1.93
- KLTOW N/A
- Resistance Level
- INO $2.25
- KLTOW N/A
- Average True Range (ATR)
- INO 0.16
- KLTOW 0.00
- MACD
- INO -0.05
- KLTOW 0.00
- Stochastic Oscillator
- INO 3.00
- KLTOW 0.00
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.